Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJuridica Investments Regulatory News (JIL)

  • There is currently no data for JIL

Significant New Investment & Trading Update

14 Nov 2008 07:00

RNS Number : 1581I
Juridica Investments Limited
14 November 2008
Β 

ο»Ώ

JuridicaΒ Investments Limited

("JIL" or the "Company")

14Β NovemberΒ 2008

Significant NewΒ InvestmentΒ and Trading Update

The board ofΒ JuridicaΒ Investments Limited ("JIL" or the "Company") is pleased toΒ announce a trading update and a significantΒ newΒ investment.

Highlights:

SignificantΒ NewΒ Investment

Fields Scrantom Sullivan PLLC ("FSS"), a law firmΒ ownedΒ by the principals ofΒ JuridicaΒ Capital Management Limited,Β hasΒ entered into a partnership (the "Partnership") with a law firm to litigate 5 cases (the "Initial Portfolio").
The Company hasΒ loaned FSSΒ $62 million (the "Loan")Β to finance fees and expenses of the Initial Portfolio.
FSS is required to payΒ interest onΒ theΒ Loan atΒ aΒ rate of 12 percent compounded annuallyΒ and has enteredΒ into a swap agreementΒ with a subsidiary of the Company under which the subsidiary receives the greater ofΒ $3.5 millionΒ orΒ 36 percent of all outstanding principal and interest under the Loan each year, accruing untilΒ income received by FSS from the Partnership covers theΒ amount.
The Initial Portfolio comprisesΒ 2Β antitrustΒ price-fixing cases, 2Β antitrustΒ monopolizationΒ cases,Β andΒ 1 statutory claim against a financial institution.
The Partnership is entitled to between 12 and 20Β percent of the recoveries achieved on theΒ antitrustΒ cases within the Initial Portfolio.
FSSΒ isΒ entitled to 90 percent ofΒ revenuesΒ earned by the PartnershipΒ on the Initial PortfolioΒ after payments to third-party law firmsΒ and deductions in respect of certain third party fees and costs;Β 85 percentΒ of net revenues from any newΒ contingent fee-based casesΒ taken on by the Partnership andΒ funded by FSSΒ in the next 3 years;Β and 15 percent ofΒ net revenues fromΒ otherΒ contingent fee-based cases entered into by the Partnership in the next 3 years that do not require funding.

Trading Update

Gross profit of approximately $1.75 million on $12.0 millionΒ loanΒ made in March and repaid inΒ October 2008.
$89.8Β million invested or committedΒ as atΒ 13Β November 2008Β (including the Initial Portfolio)Β inΒ 8Β outstandingΒ investments,Β giving exposureΒ toΒ 14Β cases acrossΒ 8Β types of litigation, 7 law firms, 11 jurisdictions and 6 different market sectors.
61Β percent ofΒ the net proceedsΒ of the Company's IPOΒ nowΒ invested or committed.
SubstantialΒ pipeline of opportunities presented to the Company'sΒ investmentΒ manager.

Lord Daniel Brennan QC, chairman of JIL, commented "This investment represents a significant opportunity forΒ the Company.Β Not only doesΒ it introduceΒ the Company to a significant portfolio of antitrust litigation, but it also gives the Company exposure toΒ a pipeline of future cases that are expected to presentΒ potentialΒ investmentΒ opportunities. We are pleased with the amount of capital invested and profits realised so far and look forward to this investment broadening the portfolio."

Richard W. Fields, chairman ofΒ JuridicaΒ Capital Management Limited, commented "We are particularly excited by this investment. Although this type ofΒ structure was anticipated at Admission, it represents a significant new product offering for the Company and a significant move into antitrust litigation. We believeΒ these kinds of casesΒ present an attractive risk profile for investment andΒ given the scaleΒ and dynamicsΒ of antitrust litigation thisΒ is a sector with significant demand for finance."

Contacts

Richard W. Fields

JuridicaΒ Capital ManagementΒ (UK)Β Limited

+1 (866) 443-1080

Nicholas Wells/Camilla Hume

Cenkos Securities plcΒ 

(Nominated Adviser & Broker)

+44 (0) 20 7397 8900

Β Β JuridicaΒ Investments Limited

("JIL" or the "Company")

14Β NovemberΒ 2008

SignificantΒ NewΒ InvestmentΒ and Trading Update

Significant Investment

The board ofΒ JuridicaΒ Investments Limited ("JIL" or the "Company") is pleased to announceΒ thatΒ JILΒ has agreed to provideΒ a loan ofΒ $62Β million (the "Loan") to Fields Scrantom Sullivan PLLC ("FSS"). FSS is a Washington DC-based law firm controlled by Timothy D. Scrantom and Richard W. Fields, whoΒ areΒ alsoΒ both principals ofΒ JuridicaΒ Capital Management Limited ("JCML" or the "Manager"), the Company's manager. The Loan will be applied to payΒ certainΒ fees and expenses of fiveΒ majorΒ cases (the "Initial Portfolio"), two of which are in the antitrust price-fixing area, two of which are antitrustΒ monopolyΒ cases,Β and the last of which is based on statutory claims against a financial institution. FSS is a partner in a law firm (the "Partnership") which has entered into agreementsΒ with a majorΒ U.S.Β law firm to litigate the Initial Portfolio.

All cases in the Initial Portfolio areΒ beingΒ litigated under contingent fee agreements. The Partnership is entitled to between 12 and 20 percent of the recoveries achieved on theΒ antitrustΒ cases within the Initial Portfolio. FSS will be entitled to 90 percent ofΒ revenuesΒ earned by the Partnership on the Initial PortfolioΒ after deductions in respect of certainΒ case revenues attributable to third-party law firms and deductions in respect of certainΒ third-party fees and costs. In addition, FSS will be entitled to 85 percent of anyΒ net revenues arising from new cases funded by FSS throughΒ the Partnership in the next threeΒ years (which FSSΒ mayΒ agree to financeΒ in its discretion)Β and 15 percent ofΒ net revenues from otherΒ non-funded contingent fee casesΒ of the Partnership.

FSS is required toΒ pay interestΒ on the Loan at aΒ rate ofΒ 12 percentΒ perΒ annum.Β Β Except at the end of the term of the Loan when all accrued and unpaid interest must be paid, interest is only payable on the Loan to the extent that income received by FSS from the Partnership covers such interest. In addition, FSS will be required to payΒ the greater of $3.5 millionΒ orΒ 36 percentΒ of all outstanding principalΒ and interestΒ under the Loan to a wholly-owned subsidiary of JILΒ each year (to the extent that income received by FSS from the Partnership covers the relevant amount)Β in consideration for such subsidiary guaranteeing repayment of the LoanΒ and accrued interestΒ by FSSΒ to JILΒ at the end of the term of the Loan. Further details of FSS's agreements with JILΒ and its subsidiaryΒ are set out below.

The Initial Portfolio

As outlined above, the Initial Portfolio consists of fiveΒ separateΒ cases. The aggregate value expected to be claimed by plaintiffs represented by the Partnership is in excess ofΒ $8Β billion, although settlement valuesΒ areΒ expected to be considerably lower. The aggregate market capitalization of the defendants named in the Initial Portfolio was in excess ofΒ $0.5Β trillion onΒ 6Β NovemberΒ 2008. The Initial PortfolioΒ is relatively risk-diverse, with significant differences inΒ the types and identities of the parties,Β case jurisdiction,Β products and markets involved,Β and legal theories and strategies implicated.

Part of the Loan from JIL to FSS will fund the initial costΒ toΒ the PartnershipΒ of past fees and costsΒ expendedΒ inΒ prosecutingΒ the Initial Portfolio,Β amounting to $8.8Β million. The Loan will also fund further payments in respect of future litigation fees and expensesΒ on the Initial Portfolio.Β Β TheΒ maximum exposureΒ to FSSΒ for such further fees and expensesΒ is capped atΒ $50.7Β million,Β and it is anticipated that this will be made available to the Partnership over the next three years.Β Β An additionalΒ $2.5Β millionΒ will be reserved to cover other costs associated with the Initial PortfolioΒ including insurance against the possibility of adverse costs awards.

Antitrust Litigation

AntitrustΒ litigation oftenΒ alleges either abuse by a monopoly of its marketΒ powerΒ to exclude other market participants or collusion by a group of market participants to set prices. In theΒ UnitedΒ States, claims are typically brought underΒ theΒ Sherman Act or the Clayton Act,Β and/orΒ price-fixing legislation. In the EuropeanΒ Union, similar behaviour is prohibited byΒ EUΒ competitionΒ laws.

Civil antitrustΒ litigationΒ againstΒ cartels often follows successful criminal investigations. The litigation strategy may involve targeted settlement with some members of the cartel prior to others. Any co-operation by these 'early settlers' with plaintiffs in theΒ litigation would be expected to make the case with remaining defendants lessΒ difficultΒ to prove. In addition,Β some antitrust lawsΒ in theΒ USΒ provideΒ for plaintiffs to be awarded treble damages in certain circumstances. These features of antitrust litigationΒ against members of a cartelΒ - prior convictions, co-operation by members of the cartel and theΒ opportunityΒ for treble damages - constitute an attractive risk profile for investment in litigation. Nonetheless, antitrust litigation is typically complicated and fact-intensive as it involves complex economic analyses of market pricing;Β proof of collusion;Β and,Β in monopoly cases,Β demonstration ofΒ market dominance. Accordingly, this field of litigation is oftenΒ expensive,Β and plaintiffs who have suffered from price-fixing often seek external finance. In theΒ US, this finance is sometimesΒ providedΒ byΒ the plaintiff's law firmΒ prosecuting the case on a contingency basis. Two of the cases in the Initial Portfolio involveΒ chargesΒ of price-fixingΒ (by an allegedΒ cartel).

The Loan and Associated Agreements

JIL has loaned FSS $62 million at a compounding annual interest rate of 12 percent pursuant to a loan agreement and promissory note (the "Note"). The Loan and Note are repayable over 10 years and are secured by FSS's economic interests in the Partnership and outcomes of the Initial Portfolio of cases.

InΒ light of the fact that the Loan and Note areΒ with recourse to FSSΒ (but not the FSS members) at the end of the term of the Loan,Β FSSΒ has entered into aΒ swapΒ agreement with Riverbend Investments Limited ("Riverbend"), a wholly-owned subsidiary of JILΒ (the "Swap").Β Β Under the Swap,Β Riverbend will pay FSS any amountsΒ payable under the LoanΒ orΒ NoteΒ at the end of the term of the Loan, to the extent that FSS does not have sufficient income from the Partnership toΒ allow such payment.Β As consideration, Riverbend will beΒ entitled to an annual amount equal toΒ the greater of US $3.5 million orΒ 36 percent of the principalΒ and interestΒ thenΒ due under the LoanΒ and NoteΒ (subject to FSS having sufficientΒ income received from the PartnershipΒ to pay the same). Under a standby supportΒ arrangement, JIL has agreed to provide RiverbendΒ with funding to enableΒ Riverbend toΒ perform its obligationsΒ underΒ the Swap.

Trading Update

The Board ofΒ JuridicaΒ isΒ pleased to announce thatΒ JILΒ hasΒ realised a grossΒ profit of $1.75 million onΒ an investmentΒ of $12 million made during March 2008. As atΒ 14Β NovemberΒ 2008, following the Loan detailed above,Β the aggregate value ofΒ the Company'sΒ investments and commitments wasΒ $89.8Β millionΒ representing approximatelyΒ 61Β percent of the net proceeds of the Company's IPO. The Loan represents approximatelyΒ 84Β percent of the amount available for commitmentΒ viaΒ indirect investmentsΒ (50 percentΒ of theΒ netΒ proceeds of the Company's IPO). This does not include realized investments.

JIL has made 10 investments in 15 cases to date and has realised investments in 2 cases. By virtue of 8 of its outstanding investments, JIL currently has exposure to 14 cases across 8 types of litigation, 7 law firms, 11 jurisdictions and 6 different market sectors.

Contacts

Richard W. Fields

JuridicaΒ Capital ManagementΒ (UK)Β Limited

+1 (866) 443-1080

Nicholas Wells/Camilla Hume

Cenkos Securities plcΒ 

(Nominated Adviser & Broker)

+44 (0) 20 7397 8900

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCEAEFLFLKPFEE
Date   Source Headline
20th Dec 201812:04 pmRNSResult of General Meeting and Cancellation
20th Dec 20187:30 amRNSSuspension - Juridica Investments Limited
20th Dec 20187:00 amRNSSuspension of Shares
17th Dec 20185:30 pmRNSJuridica Investments
14th Dec 201811:05 amRNSSecond Price Monitoring Extn
14th Dec 201811:00 amRNSPrice Monitoring Extension
12th Dec 20184:35 pmRNSPrice Monitoring Extension
11th Dec 20182:05 pmRNSSecond Price Monitoring Extn
11th Dec 20182:00 pmRNSPrice Monitoring Extension
28th Nov 20182:41 pmRNSPosting of Circular
28th Nov 201810:23 amRNSDividend Declaration
22nd Nov 20182:06 pmRNSSecond Price Monitoring Extn
22nd Nov 20182:00 pmRNSPrice Monitoring Extension
22nd Nov 20187:00 amRNSWinding up, Delisting & Notice of General Meeting
7th Sep 20184:40 pmRNSSecond Price Monitoring Extn
7th Sep 20184:35 pmRNSPrice Monitoring Extension
6th Sep 20186:00 pmRNSResults for the six months ended 30 June 2018
28th Jun 201810:03 amRNSAnnual Financial Report
13th Jun 201810:00 amRNSResult of AGM
4th Apr 201811:30 amRNSFinal Results
10th Jan 20185:00 pmRNSCompany Update
22nd Aug 20177:00 amRNSResults for the six months ended 30 June 2017
20th Jun 201712:18 pmRNSAnnual Financial Report
4th May 20175:31 pmRNSResult of Annual General Meeting
3rd Apr 20177:00 amRNSFinal Results
18th Jan 20177:00 amRNSInvestment Manager ownership change
16th Dec 20163:44 pmRNSTotal Voting Rights
22nd Sep 201610:00 amRNSHolding(s) in Company
21st Sep 20163:55 pmRNSHolding(s) in Company
13th Sep 20163:11 pmRNSHolding(s) in Company
7th Sep 20163:54 pmRNSDividend Payment Date
6th Sep 20164:15 pmRNSHalf-year Report
1st Aug 20165:17 pmRNSHolding(s) in Company
28th Jul 20165:33 pmRNSHolding(s) in Company
19th Jul 20163:08 pmRNSHolding(s) in Company
19th Jul 201612:43 pmRNSHolding(s) in Company
6th Jul 20169:06 amRNSHolding(s) in Company
19th May 20167:00 amRNSDividend Declaration
10th May 20166:07 pmRNSResult of AGM
11th Apr 20161:15 pmRNSNotice of AGM
11th Apr 201610:30 amRNSPortfolio update
31st Mar 20169:42 amRNSFinal Results
8th Feb 20167:00 amRNSStatement re: Company costs
4th Dec 20153:48 pmRNSHolding(s) in Company
19th Nov 20159:55 amRNSReplacement: Holdings in Company
19th Nov 20157:00 amRNSHolding(s) in Company
18th Nov 20157:00 amRNSCorporate update
17th Nov 20153:28 pmRNSHolding(s) in Company
16th Nov 20157:00 amRNSPortfolio Update
2nd Oct 201512:52 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.